Viral Plex
Viral Plex, licence 80071507: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Natural Equivalents Incorporated
- NPN or DIN-HM
- 80071507
- Status
- Active licence
- Licence date
- 28 July 2016
- Revision date
- Not provided
- Form
- Gouttes orales
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poliomyélite Source : Liquide céphalorachidien obtenu par ponction lombaire sur des patients atteints de poliomyélite | 13.0 CH | Not calculated |
| Coxsackie Source : Virus Coxsackie inactivé des sous-groupes A9 et B4 | 13.0 CH | Not calculated |
| Diphtherinum Source : Membrane infectée de diphtérie | 13.0 CH | Not calculated |
| Epstein Barr Source : Virus Epstein Barr | 13.0 CH | Not calculated |
| Herpes simplex Source : Sécrétions de Herpes simplex provenant des vésicules | 13.0 CH | Not calculated |
| Herpes zoster Source : Sécrétions provenant des vésicules de la varicelle à divers endroits et à divers stades | 13.0 CH | Not calculated |
| Influenzinum Source : Virus de la grippe A et B inactivé provenant de l'embryon de poulet, individuellement ou en combinaison | 10.0 X | Not calculated |
| Mononucléose Source : Salive de patients atteints de la fièvre glandulaire (mononucléose) causée par le virus Epstein-Barr | 13.0 CH | Not calculated |
| Morbillinum Source : Exudats bucco-pharyngés provenant des humains infectés avec la rougeole | 13.0 CH | Not calculated |
| Euphrasia officinalis Source : Plante entière | 8.0 X | Not calculated |
Non-medicinal ingredients
Éthanol, Lactose, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 13.0 Année(s) | 10.0 Goutte(s) | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Nosodes Medicine
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80071507
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.